T lymphocytes promote the development of bone marrow-derived APC in the Central Nervous System

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 370-376

  Subramanian, S ^a   Bourdette, D N ^a   Corless, C ^a   Vandenbark, A A ^a   Offner, H ^a   Jones, R E ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; CELL MATURATION; CELL TRANSFER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; INFLAMMATION; MACROPHAGE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PARALYSIS; PATHOGENESIS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SCID MOUSE; T LYMPHOCYTE;

EID: 0035164361     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.370     Document Type: Article

References (49)

1. Relative susceptibility of SJL/J and B10.S mice to experimental allergic encephalomyelitis is correlated with high and low responsiveness to myelin basic protein
2. A combination of adoptive transfer and antigenic challenge induces consistent murine experimental autoimmune encephalomyelitis in C57BL/6 mice and other reputed resistant strains
3. TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system
4. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis
5. Increased frequency of interleukin-2 responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
6. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide
7. Escape from "Horror Autotoxicus": Pathogenesis and treatment of autoimmune disease
8. Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein
9. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor Vβ-specific antibodies
10. Surface expression of an integrin by CD4 T cells is required for their entry into brain parenchyma
11. + population during recovery
12. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides
13. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes
14. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis
15. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis
16. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
17. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS
18. Immune surveillance and autoantigen recognition in the central nervous system
19. Cellular immune reactivity within the CNS
20. T-lymphocyte entry into the central nervous system
21. Biophysical studies of T-cell receptors and their ligands
22. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes
23. Function of macrophages in antigen recognition by guinea pig T lymphocytes. II. Role of the macrophage in the regulation of genetic control of the immune response
24. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system
25. Transfer of experimental allergic encephalomyelitis to bone marrow chimeras: Endothelial cells are not a restricting element
26. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
27. Bone marrow-derived elements in the central nervous system: An immunohistochemical and ultrastructural survey of rat chimeras
28. + T-cell lines in multiple sclerosis
29. + T Cells from multiple sclerosis patients
30. Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis
31. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental antoimmune encephalomyelitis
32. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
33. Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis
34. Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells
35. A severe combined immunodeficiency mutation in the mouse
36. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function
37. Long-term hematopolesls in the SCID-hu mouse
38. In vivo models of human lymphopoiesis and autoimmunity in severe combined immunodeficient mice
39. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice
40. Phenotype and function of hematopoletic-derived cells in the CNS of SCID mouse-Lewis rat bone marrow chimeras
41. Coexpression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells
42. Expression of major histocompatibility complex class II molecules in rat T cells
43. The pathogenesis of senile plaques
44. Microglia: Intrinsic immuneffector cell of the brain
45. Transplantation of activated macrophages overcomes central nervous system regrowth failure
46. Microglia: A sensor to threats in the nervous system?
47. In situ detection of transforming growth factor-β mRNA in experimental rat glioma and reactive glial cells
48. Response of microglial cells to experimental rat glioma
49. Cellular and molecular neurosurgery: Pathways from concept to reality. II. Vector systems and delivery methodologies for gene therapy of the central nervous system